Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Association of Complement Factors With Disability Progression in Primary Progressive Multiple Sclerosis

24 Jun 2024

Abstract excerpt

BACKGROUND AND OBJECTIVES: The complement system is known to play a role in multiple sclerosis (MS) pathogenesis. However, its contribution to disease progression remains elusive. The study investigated the role of the complement system in disability progression of patients with primary progressive MS (PPMS). METHODS: Sixty-eight patients with PPMS from 12 European MS centers were included in the study. Serum and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Complement system in diseases
Share to Multiple Sclerosis Research Studies
Share to Neuroinflammation and Neurodegeneration Mechanisms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38912898
DOI: 10.1212/nxi.0000000000200270

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Association of Complement Factors With Disability Progression in Primary Progressive Multiple SclerosisPMID 38912898Read ↗

Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple SclerosisSemantic proximity Read ↗

Complement Activation Is Associated With Disease Severity in Multiple SclerosisSemantic proximity Read ↗

Complement in multiple sclerosis: its role in disease and potential as a biomarker.Semantic proximity Read ↗

Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody–Associated DiseaseSemantic proximity Read ↗

The good, the bad, and the opportunities of the complement system in neurodegenerative diseaseSemantic proximity Read ↗

Plasma proteome in multiple sclerosis disease progressionSemantic proximity Read ↗

Tissue microarray methodology identifies complement pathway activation and dysregulation in progressive multiple sclerosisSemantic proximity Read ↗

Complement C3c Reflects Acute-Phase Response but Not Clinical Phenotype in Systemic Sclerosis: A Cross-Sectional Study.Semantic proximity Read ↗

Genetic Insights into Circulating Complement Proteins in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Potential Inflammatory SubgroupSemantic proximity Read ↗

Genetic Insights into Circulating Complement Proteins in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Potential Inflammatory Subgroup.Semantic proximity Read ↗

Role for terminal complement activation in amyotrophic lateral sclerosis disease progressionSemantic proximity Read ↗

Correlation of selected serum protein levels with the degree of disability and NEDA-3 status in multiple sclerosis phenotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.